A Study to Compare Two Bioanalytical Assays for Tebipenem

NCT05856747 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Spero Therapeutics